Literature DB >> 15272411

Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3.

Igor Theurl1, Heinz Zoller, Peter Obrist, Christian Datz, Felix Bachmann, Richard M Elliott, Guenter Weiss.   

Abstract

BACKGROUND: Although the response to treatment with interferon- alpha in individuals with chronic hepatitis C virus (HCV) infection is negatively associated with increased liver iron stores, the underlying mechanisms at work have remained elusive to date. The translation initiation factor 3 (eIF3) is essential for HCV translation, and thus the effects that iron perturbations have on eIF3 expression and HCV translation were studied here.
METHODS: eIF3 expression was analyzed by TaqMan polymerase chain reaction, Northern and Western blot analysis of HepG2 cells, and liver biopsies. Functional effects of iron on HCV mRNA translation were estimated by use of transient transfection experiments with bicistronic vectors.
RESULTS: Iron treatment of HepG2 cells increased eIF3 mRNA and protein expression, whereas iron chelation reduced it. Accordingly, iron-dependent stimulation of eIF3 specifically induced the expression of reporter genes under the control of regulatory HCV mRNA stem-loop structures. Moreover, a positive association between liver iron levels, eIF3 expression, and HCV expression was found when liver-biopsy samples from HCV-infected patients were analyzed.
CONCLUSION: Iron promotes the translation of HCV by stimulating the expression of eIF3, which may be one reason for the negative association between liver iron overload and HCV infection. Modulation of the affinity of eIF3 to bind to HCV mRNA may be a promising target for the treatment of chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272411     DOI: 10.1086/422261

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

Authors:  Mark Thursz
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

2.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

3.  The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antivirals.

Authors:  Katarzyna Sikorska
Journal:  Virulence       Date:  2016-05-19       Impact factor: 5.882

Review 4.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

Review 5.  Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis.

Authors:  Manfred Nairz; Günter Weiss
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

6.  Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.

Authors:  Massimo Sartori; Silvano Andorno; Michela Pagliarulo; Cristina Rigamonti; Cristina Bozzola; Patrizia Pergolini; Roberta Rolla; Anna Suno; Renzo Boldorini; Giorgio Bellomo; Emanuele Albano
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

7.  Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.

Authors:  Hana Cho; Hyung Chul Lee; Sung Key Jang; Yoon Ki Kim
Journal:  Virus Genes       Date:  2008-06-20       Impact factor: 2.332

Review 8.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 9.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Antiviral activity of bone morphogenetic proteins and activins.

Authors:  Lucy A Eddowes; Kinda Al-Hourani; Narayan Ramamurthy; Jamie Frankish; Hannah T Baddock; Cynthia Sandor; John D Ryan; Dahlene N Fusco; João Arezes; Eleni Giannoulatou; Sara Boninsegna; Stephane Chevaliez; Benjamin M J Owens; Chia Chi Sun; Paolo Fabris; Maria Teresa Giordani; Diego Martines; Slobodan Vukicevic; John Crowe; Herbert Y Lin; Jan Rehwinkel; Peter J McHugh; Marco Binder; Jodie L Babitt; Raymond T Chung; Matthew W Lawless; Andrew E Armitage; Caleb Webber; Paul Klenerman; Hal Drakesmith
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.